Despite what you may read in the headlines, picking stocks to find the "next big thing" usually doesn't work out well in the end. For every "it" stock like Tesla Motors, there are a dozen companies whose investors were hoping for a massive payday, but are instead finding the exact opposite.
Actually, most investors who end up with million-dollar portfolios earned them by smart, aggressive saving habits combined with steady, consistently growing stocks. And one of the best ways to do this is to buy a whole lot of what you may think of as "boring" stocks, but that in reality are quite the opposite.
Source: Flickr/401(k) 2013
The type of stocks you need
Basically, when investing for the long term, the best way to go about choosing your stocks is to put yourself in a defensive mind-set. In other words, you need to worry more about preventing losses than creating huge gains.
5 Best Computer Hardware Stocks To Invest In 2015: Konared Corp (KRED)
KonaRed Corporation., formerly TeamUpSport Inc., incorporated on October 4, 2010, is a development-stage company. The Company is focused to develop and commercialize on its Website www.teamupsport.com. As of May 31, 2011, the Company had not generated revenue. On October 4, 2013, the Company acquired Sandwich Isles Trading Co. Inc. dba KonaRed.
The Company's Website will be designed to integrate into a single online offering people�� interest in sports with the capabilities of online social networking. The Website will become a sports focused social networking Website.
Advisors' Opinion:- [By Bryan Murphy]
Look out PepsiCo, Inc. (NYSE:PEP) and The Coca-Cola Company (NYSE:KO). While you may be the de facto leaders in the overall beverage race, you've got a vulnerability a smaller - and better - competitor is going to exploit. And worse, that competitor now has a partner that could make it an even more formidable enemy... and that partner used to be an enemy, of sorts. The competition The Coca-Cola Company and PepsiCo (and by extension, KO and PEP shareholders) need to worry about is Konared Corp. (OTCBB:KRED). While it's inconceivable that KRED would ever dethrone the two kings of the beverage world, it's quite conceivable that Konared and its new partner could make life difficult for Coke and Pepsi, while carving out a solid piece of a particular market for itself.
- [By John Udovich]
Monster Beverage Corp (NASDAQ: MNST), a mid cap marketer and distributor of energy drinks and alternative beverages, has been a monster of a performer since the end of the financial crisis as the stock is up around 308% over the past five years, but could new or overlooked players like small cap beverage stocks�Jones Soda Co (OTCMKTS: JSDA), Celsius Holdings, Inc (OTCMKTS: CELH) and Konared Corp (OTCBB: KRED) repeat that performance? A look strictly at the long term performance of all three small caps might have you thinking otherwise. After all, none of these small cap beverage stocks are profitable while�the beverage industry can be a long hard expensive slog just to increase market share by one or two points when you are competing for shelf space with industry giants like Pepsi and Coke. But past performance is just that���the past and only part of the story as there is much more to consider about these small cap beverage stocks which could also make them potential acquisition targets by larger beverage players seeking to expand their product line up with innovative products:
Hot Defensive Stocks To Invest In Right Now: DCT Industrial Trust Inc (DCF)
DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc. is the sole general partner. The Company owns properties through its operating partnership and its subsidiaries. As of December 31, 2011, DCT owned approximately 90% of the outstanding equity interests in its operating partnership. In March 2012, DCT acquired a 32.6 acre land parcel in Romeoville, within the southern I-55 industrial submarket of Chicago. In May 2012, the Company acquired two Class A industrial buildings totaling 98,000 square feet in Houston, known as DCT Claymoore Center. Located in the Northwest submarket of Houston, DCT Claymoore Center encompasses a bulk and light industrial facility and is 95.8%-occupied. In August 2013, the Company announced that it has acquired a three building portfolio totaling 308,000 square feet in the Tempe/Airport submarket of Phoenix. In September 2013, Dct Industrial Trust Inc announced the acquisition of 45 acres in the heart of the Inland Empire West submarket of Southern California. In October 2013, DCT Industrial Trust Inc acquired DCT Fox River Business Center, a six-building industrial portfolio in Elgin. In October 2013, DCT Industrial Trust Inc sold its entire portfolio of Mexico assets to an investment trust of Macquarie Mexican REIT.
During the year ended December 31, 2011, the Company acquired 24 buildings comprising 2.8 million square feet and controlling ownership interests in three buildings totaling 0.4 million square feet. In 2011, the Company sold 16 operating properties to! taling approximately 2.7 million square feet to third-parties. As of December 31, 2011, the Company�� consolidated operating properties had leases with approximately 900 customers with no single customer accounting for more than 1.7% of the total annualized base rents of its properties. As of December 31, 2011, the Company owned interests in, managed or had under development approximately 75.5 million square feet of properties leased to approximately 900 customers, including 58.1 million square feet comprising 408 consolidated properties owned in its operating portfolio, which were 90.6% occupied; 0.2 million square feet comprising one consolidated property under redevelopment, and 17.2 million square feet comprising 52 unconsolidated properties, which were 86.3% occupied and one managed-only property operated on behalf of five institutional capital management partners. As of December 31, 2011, its total consolidated portfolio consisted of 409 properties with an average size of 142,000 square feet and an average age of 20.2 years.
Advisors' Opinion:- [By David Kerr]
Let�� take a look at using a version of the Discounted Cash Flow method (DCF) to valuate the share price. I will use the most recent Earnings Per Share of 2.32, an 18.9% growth rate over the next 10 years (which is the average EPS growth rate of the past 10 years), a Terminal Growth Rate of 2% (average inflation rate for 2013 so far), with 10 years of Terminal Growth at a Discount Rate of 12% to be safe. That leaves us with a Fair Value of $58.85 and a 42% Margin of Safety. That�� a healthy margin.
- [By Robert Rapier]
The partnership has generated $7.6 billion of distributable cash flow (DCF) over the past nine years, paying out just short of three quarters of that total and reinvesting the rest. The long-term distribution coverage checks in at a prudent 134%.
- [By GuruFocus]
Free cash flow is a favorite parameter of value investors. It seems to make sense, because the value of a company is determined by how much cash it can generate over time. Value investors have developed discounted cash flow (DCF) models to estimate the value of companies.
- [By Canadian Value]
As many of our clients know, Jensen focuses primarily on the discounted cash flow (DCF) method to value equities. Our long held belief is that the intrinsic value of a business is the present value of the cash flows the company is expected to pay its shareholders in the future. The remainder of this paper explores some of the advantages and disadvantages of using either DCF or multiples and outlines why we believe DCF is the more fundamentally sound way to value equities.
Hot Defensive Stocks To Invest In Right Now: Teledyne Technologies Incorporated (TDY)
Teledyne Technologies Incorporated provides instrumentation, digital imaging products and software, aerospace and defense electronics, and engineered systems in the United States and internationally. The company?s Instrumentation segment provides monitoring and control instruments for marine, environmental, scientific, industrial, and defense applications, as well as harsh environmental interconnect products. Its Digital Imaging segment includes sponsored and centralized research laboratories benefiting government programs and businesses, as well as development efforts for innovative digital imaging products for government and space applications. It also includes infrared detectors, cameras, and optomechanical assemblies. Teledyne Technologies? Aerospace and Defense Electronics segment provides electronic components and subsystems and communications products, including defense electronics, data acquisition, and communications equipment for air transport and business aircra ft and components and subsystems for wireless and satellite communications, as well as general aviation batteries. The company?s Engineered Systems segment provides systems engineering and integration, advanced technology application, software development, and manufacturing solutions to space, military, environmental, energy, chemical, biological and nuclear systems, and missile defense requirements. This segment also designs and manufactures hydrogen generators, thermoelectric and fuel-cell based power sources, and small turbine engines. Teledyne Technologies? customers include government agencies, aerospace prime contractors, energy exploration and production companies, industrial companies, and airlines. The company was founded in 1960 and is headquartered in Thousand Oaks, California.
Advisors' Opinion:- [By Geoff Gannon]
We should be careful to overstate the tax aspect of buybacks. For example, Q-Logic has a lot of cash overseas (almost all of its $500 million). The company could ��in theory ��make several tender offers for close to 50% of its market cap with that cash. This is the Teledyne (TDY) approach. Q-Logic doesn�� do that for several reasons. One, it likes having some cash on hand at all time. But, more importantly, it doesn�� want to pay the tax.
- [By Monica Gerson]
Teledyne Technologies (NYSE: TDY) announced its plans to acquire Bolt Technology (NASDAQ: BOLT) for $22 per share. Bolt shares climbed 38.84% to $21.71 in the after-hours trading session, while Teledyne shares fell 0.29% to close at $97.40 yesterday.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Teledyne Technologies (NYSE: TDY ) , whose recent revenue and earnings are plotted below.
Hot Defensive Stocks To Invest In Right Now: Sino-Global Shipping America Ltd.(SINO)
Sino-Global Shipping America, Ltd., through its subsidiaries, provides shipping agency services for foreign ships coming to and departing from Chinese ports. Its services include preparing documents, husbanding vessels, working through customs issues, coordinating matters with port authorities, overseeing and settling cargo claims, tracking shipments, recommending trucking, warehousing, and complementary services. The company offers these services for bulk and break-bulk general cargo, and vehicle transport, as well as raw materials, such as crude oil, oil products, iron, manganese, and other metal ores in 76 ports in the People?s Republic of China. Sino-Global Shipping America, Ltd. was founded in 2001 and is based in Flushing, Virginia.
Advisors' Opinion:- [By James E. Brumley]
The recent strength from Sino-Global Shipping America, Ltd. (NASDAQ:SINO) and the now-renewed strength from Safe Bulkers, Inc. (NYSE:SB) would suggest those two stocks are among the very best ways to play the rebound currently unfurling in the shipping sector. And to be fair, both are fine companies in their own right. The top play in the dry goods maritime shipping arena, however, may well be Diana Shipping Inc. (NYSE:DSX). No, DSX isn't one of the fun and exciting small caps in the maritime shipping space. But, there's a lot to be said for size and stability, which SB and SINO can't offer.
Hot Defensive Stocks To Invest In Right Now: Shire PLC (SHPG)
Shire plc (Shire), incorporated on January 28, 2008, is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. As of December 31, 2012, the Company�� products included VYVANSE/VENVANSE (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) modified release (XL), LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), FOSRENOL (lanthanum carbonate), XAGRID (anagrelide hydrochloride), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant) and DERMAGRAFT(Human Fibroblast-Derived Dermal Substitute). As of December 31, 2012, the Company�� products under development included INTUNIV (extended release guanfacine), VYVANSE/VENVANSE (lisdexamfetamine dimesylate), INTUNIV, Guanfacine Carrier Wave, LIALDA (mesalamine)/MEZAVANT (mesalazine), RESOLOR (prucalopride), RESOLOR (prucalopride), SPD 557(M0003), XAGRID, VYVANSE (lisdexamfetamine dimesylate), REPLAGAL (agalsidase alfa), HGT-4510, HGT-2310, HGT-1410, HGT-1110, HGT-3010, and DERMAGRAFT. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.
VANSE/ VENVANSE
VYVANSE is a New Chemical Entity (NCE) and is the pro-drug stimulant for the treatment of ADHD, where the amino acid l-lysine is linked to d-amphetamine. VYVANSE is therapeutically inactive until metabolized in the body. The United Stat! es Food and Drug Administration approved VYVANSE as a once-daily treatment for children aged 6 to 12 with ADHD in February 2007, for adults in April 2008 and for adolescents aged 13 to 17 in November 2010. VYVANSE is available in the United States in six dosage strengths: 20 milligram, 30 milligram, 40 milligram, 50 milligram, 60 milligram and 70 milligram. Health Canada approved VYVANSE for the treatment of ADHD in pediatric patients aged 6 to 12 in February 2009, and for adolescents and adults in November 2010. In April 2012, ANVISA, the Brazilian health authority, granted marketing authorization approval for lisdexamfetamine dimesylate for the treatment of ADHD in children aged 6-12.
ADDERALL XR
ADDERALL XR is an extended release treatment for ADHD, which uses MICROTROL drug delivery technology and is designed to provide once-daily dosing. It is available in 5 milligram, 10 milligram, 15 milligram, 20 milligram, 25 milligram and 30 milligram capsules and can be administered either as a capsule or sprinkled on soft food. The United States Food and Drug Administration has approved ADDERALL XR as a once-daily treatment for children aged 6 to 12 with ADHD, for adults in and for adolescents aged 13 to 17. Teva Pharmaceutical Industries, Ltd. (Teva) and Impax Laboratories, Inc. (Impax) commenced commercial shipment of their authorized generic versions of ADDERALL XR in April and October 2009, respectively. Shire receives royalties from Impax�� sales of authorized generic ADDERALL XR.
INTUNIV
INTUNIV is a selective alpha-2A receptor agonist indicated for the treatment of ADHD. Alpha-2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signalling in the prefrontal cortex (Cell. 2007; 129:397-410). INTUNIV is non-scheduled and has no known potential for abuse or dependence. The United States Food and Drug Administration approved INTUNIV in September 2009, as a once-daily monotherapy treatment of ADHD in children and adolesce! nts aged ! 6 to 17. It is available in 1 milligram, 2 milligram, 3 milligram and 4 milligram tablets.
EQUASYM
Shire has acquired from UCB the worldwide rights (excluding the United States, Canada and Barbados) to EQUASYM (methylphenidate hydrochloride) IR and XL for the treatment of ADHD in children and adolescents aged 6 to 18. At December 31, 2012,EQUASYM XL was commercially available in 10 countries in 10mg, 20mg and 30mg strengths. EQUASYM XL is marketed in Mexico and South Korea under the trade name METADATE CD.
LIALDA/MEZAVANT
LIALDA is indicated for the induction ofmild to moderately active UC and for the maintenance of remission of UC. The addition of the indication for maintenance of remission of ulcerative colitis was approved by Health Canada in February 2011, and by the United States Food and Drug Administration in July 2011. LIALDA is once-daily oral formulation of mesalamine indicated for the induction and maintenance of remission. As of December 31, 2012, LIALDA/MEZAVANT (this product is marketed outside the United States as MEZAVANT) was commercially available in 19 countries either directly or through distributor arrangements.
PENTASA
PENTASA controlled release capsules are approved in the United States (marketed by Shire in the United States and by Ferring outside of the United States) and indicated for the induction of remission and for the treatment of patients with mild to moderately active ulcerative colitis. PENTASA is an ethylcellulose-coated, controlled release capsule formulation designed to release therapeutic quantities of mesalamine throughout the gastrointestinal tract. PENTASA is available in the United States in 250 milligram and 500 milligram capsules.
RESOLOR
RESOLOR (prucalopride), a 5-HT4 receptor agonists that stimulates gastrointestinal motility and acts primarily on different parts of the lower gastrointestinal tract (enterokinetic). In October 2009, RESOLOR was appr! oved by t! he EMA throughout the European Union as a once daily oral treatment for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. In July 2010, Swissmedic granted RESOLOR marketing authorization in Switzerland for the treatment of idiopathic chronic constipation in adults. RESOLOR is available in milligram and 2 milligram dose strengths, both for once-daily dosing. At December 31, 2012, RESOLOR was available in six European Union countries. Formulated as a chewable tablet, FOSRENOL is available in 500 milligram, 750 milligram and 1,000 milligram dosage strengths.
XAGRID
XAGRID (anagrelide hydrochloride) is marketed in Europe for the reduction of elevated platelet counts in at-risk ET patients. XAGRID has been granted orphan drug status in the European Union. In the United States, anagrelide hydrochloride is sold by the Company under the name AGRYLIN for the treatment of thrombocythemia secondary to a MPD.
REPLAGAL
REPLAGAL is for the treatment of Fabry disease. Fabry disease is a genetic disorder resulting from a deficiency in the activity of the lysosomal enzyme alpha-galactosidase A, which is involved in the breakdown of fats. REPLAGAL is a human alpha-galactosidase A protein made in human cells that replaces the deficient alpha-galactosidase A with an active enzyme to ameliorate certain clinical manifestations of Fabry disease. At December 31, 2012, REPLAGAL was approved in 46 countries.
ELAPRASE
ELAPRASE is a treatment for Hunter syndrome (also known as Mucopolysaccharidosis Type II or MPS II). Hunter syndrome is a genetic disorder mainly affecting males that interferes with the body's ability to break down and recycle waste substances called mucopolysaccharides, also known as glycosaminoglycans (GAGs). ELAPRASE was approved by the United States Food and Drug Administration and granted marketing authorization by the EMA for the long term treatment of patients with Hunter ! syndrome.! ELAPRASE has been granted orphan drug by both the United States Food and Drug Administration and the EMA. ELAPRASE received approval from the Ministry of Health, Labour and Welfare in Japan. At December 31, 2012, ELAPRASE was approved in 51 countries.
VPRIV
VPRIV is a treatment for Type 1 Gaucher disease. Gaucher disease is an inherited genetic disorder, which results in a deficiency of the lysosomal enzyme beta-glucocerebrosidase. VPRIV was approved by the United States Food and Drug Administration in February 2010, for the long-term treatment of patients with Type 1 Gaucher disease. The EMA approved the marketing authorization for the use of VPRIV in August 2010. VPRIV was authorized as an orphan medicine through the Centralised Procedure in Europe. At December 31, 2012, VPRIV was approved in 38 countries.
FIRAZYR
FIRAZYR is a peptide-based therapeutic developed for the symptomatic treatment of acute attacks of HAE. In July 2008 the EMA granted marketing authorization throughout the European Union for the use of FIRAZYR for the symptomatic treatment of acute attacks of HAE, and in May 2011 approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. In August 2011, the United States Food and Drug Administration granted marketing approval for FIRAZYR in the United States for treatment of acute attacks of HAE in adults aged 18 and older. After injection training, patients may self-administer FIRAZYR. FIRAZYR has been granted orphan drug by both the United States Food and Drug Administration and the EMA. At December 31, 2012, FIRAZYR was approved in 38 countries globally.
DERMAGRAFT
DERMAGRAFT is a bio-engineered skin substitute that assists in restoring damaged tissue. DERMAGRAFT is indicated for use in the treatment of full-thickness Diabetic foot ulcers (DFU) greater than six weeks in duration, which extend through the dermis, but without tendon, muscle, joint capsu! le, or bo! ne exposure. DERMAGRAFT is approved by the United States Food and Drug Administration as a Class III medical device for the treatment of DFUs. DERMAGRAFT is also approved for the treatment of DFUs in South Africa, Israel and Singapore.
The Company competes with Shionogi & Co., Ltd., Janssen-Cilag, Novartis, Medice, Eli Lilly, Warner Chilcott, Synergy Pharmaceuticals, Inc., ARYx Therapeutics, Theravance, Inc., Sucampo Pharmaceuticals, Inc., Albireo, Actelion Ltd., Protalix BioTherapeutics Inc, Genzyme, CSL Behring, Pharming Group N.V., ViroPharma, Dyax Corporation, Organogenesis, Healthpoint, Soluble System, KCI, Smith & Nephew, Aurobindo and Apotex.
Advisors' Opinion:- [By Anna Prior]
Shire(SHPG) PLC has agreed to buy ViroPharma for $4.2 billion, extending its bet on the market for medicines treating rare diseases. The purchase price of $50 a share is a 27% premium to ViroPharma’s closing share price on Friday and a 64% premium to the price in September before speculation of a deal emerged. Shire’s American depositary shares rose 3.7% to $139.36 premarket, while ViroPharma’s shares jumped 26% to $49.58.
Hot Defensive Stocks To Invest In Right Now: Regency Energy Partners LP (RGP)
Regency Energy Partners LP (the Partnership), incorporated on September 8, 2005, is engaged in the gathering and processing, contract compression, treating and transportation of natural gas and the transportation, fractionation and storage of natural gas liquids (NGLs). The Partnership operates in five business segments: Gathering and Processing, Joint Ventures, Contract Compression, Contract Treating, and Corporate and Others. Its assets are primarily located in Texas, Louisiana, Arkansas, Pennsylvania, California, Mississippi, Alabama, West Virginia and the mid-continent region of the United States, which includes Kansas, Colorado and Oklahoma. In May 2013, Regency Energy Partners LP closed the acquisition of Southern Union Gathering Company, LLC from Southern Union Company. In February 2014, Regency Energy Partners LP closed its acquisition of the midstream business of Hoover Energy Partners LP.
During the year ended December 31, 2012, Lone Star NGL LLC (Lone Star), a newly formed joint venture that is owned 70% by Energy Transfer Partners, L.P. (ETP) and 30% by the Partnership, acquired all of the membership interest in LDH Energy Asset Holdings LLC (LDH), a wholly owned subsidiary of Louis Dreyfus Highbridge Energy LLC. The Partnership focuses on providing midstream services in some of the most prolific natural gas producing regions in the United States, including the Eagle Ford, Haynesville, Barnett, Fayetteville, Marcellus, Bone Spring, and Avalon shales as well as the Permian Delaware basin and the mid-continent region. The Partnership provides wellhead-to-market services to producers of natural gas, which include transporting raw natural gas from the wellhead through gathering systems, processing raw natural gas to separate NGLs and selling or delivering the pipeline natural gas and NGLs to various markets and pipeline systems.
The Partnership owns and operates a fleet of compressors used to provide turn-key natural gas compression services for customer specific syst! ems. The Partnership owns and operates a fleet of equipment used to provide treating services, such as carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration and BTU management, to natural gas producers and midstream pipeline companies.
Gathering and Processing Operations
The Partnership operates gathering and processing assets in four geographic regions of the United States: north Louisiana, the mid-continent region of the United States, south Texas and west Texas. The Partnership�� north Louisiana assets gather, compress, treat and dehydrate natural gas in five Parishes (Claiborne, Union, DeSoto, Lincoln and Ouachita) of north Louisiana and Shelby County, Texas. Its assets also include two cryogenic natural gas processing facilities, a refrigeration plant located in Bossier Parish, a conditioning plant located in Webster Parish, an amine treating plant in DeSoto Parish, and an amine treating plant in Lincoln Parish. The Partnership�� south Texas assets gather, compress, treat and dehydrate natural gas in LaSalle, Webb, Karnes, Atascosa, McMullen, Frio and Dimmitt counties. The pipeline systems that gather this gas are connected to third-party processing plants and its treating facilities that include an acid gas reinjection well located in McMullen County, Texas.
One of the Partnership�� treating plants consists of inlet gas compression, a 60 one million cubic feet per day amine treating unit, a 55 one million cubic feet per day amine treating unit and a 40 ton (per day) liquid sulfur recovery unit. In January 2012, it completed an expansion of the treating plant, adding an incremental 20 one million cubic feet per day of treating capacity to the facility. The Partnership owns a 60% interest in ELG that includes a treating plant in Atascosa County with a 500 gallons per minute amine treater, pipeline interconnect facilities and approximately 13 miles of ten inch diameter pipeline. Talisman Energy USA Inc. and Statoil Texas Onshore Pro! perties L! P own the remaining 40% interest. It operates this plant and the pipeline for the joint venture while its joint venture partner operates a lean gas gathering system in the Edwards Lime natural gas trend that delivers to this system.
The Partnership�� west Texas gathering system assets offer wellhead-to-market services to producers in Ward, Winkler, Reeves, and Pecos counties, which surround the Waha Hub. The NGL market outlets include Lone Star's west Texas NGL pipeline. It offers producers four different levels of natural gas compression on the Waha gathering system. The Waha processing plant is a cryogenic natural gas processing plant that processes raw natural gas gathered in the Waha gathering system. The Waha processing plant also includes an amine treating facility, which removes carbon dioxide and hydrogen sulfide from raw natural gas gathered before moving the natural gas to the processing plant.
The Partnership�� mid-continent region includes natural gas gathering systems located primarily in Kansas and Oklahoma. Its mid-continent gathering assets are extensive systems that gather, compress and dehydrate low-pressure gas from approximately 1,500 wells. These systems are geographically concentrated, with each central facility located within 90 miles of the others. The Partnership also owns the Hugoton gathering system that has approximately 1,875 miles of pipeline extending over nine counties in Kansas and Oklahoma. This system is operated by a third party. Its mid-continent systems are located in two natural gas producing regions in the United States, the Hugoton Basin in southwest Kansas and the Anadarko Basin in western Oklahoma.
Joint Ventures Operations
The Partnership owns investments in four joint ventures: a 49.99% general partner interest in RIGS Haynesville Partnership Co., a general partnership, and its wholly-owned subsidiary, Regency Intrastate Gas LP (HPC); a 50% membership interest in MEP; a 30% membership interest in Lone St! ar, and a! 33.33% membership interest in Ranch JV. HPC owns RIGS, a 450-mile intrastate pipeline that delivers natural gas from northwest Louisiana to downstream pipelines and markets. MEP owns an interstate natural gas pipeline with approximately 500 miles stretching from southeast Oklahoma through northeast Texas, northern Louisiana and central Mississippi to an interconnect with the Transcontinental Gas Pipe Line system in Butler, Alabama. Lone Star is an entity owning a diverse set of midstream energy assets, including NGL pipelines, storage, fractionation and processing facilities located in the states of Texas, Mississippi and Louisiana.
Contract Compression Operations
The natural gas contract compression segment services include designing, sourcing, owning, installing, operating, servicing, repairing and maintaining compressors and related equipment. These field-wide applications include compression for natural gas gathering and natural gas processing. The Partnership�� contract compression operations are primarily located in Texas, Louisiana, Arkansas, Pennsylvania and California.
Contract Treating Operations
The Partnership owns and operates a fleet of equipment used to provide treating services, such as carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration and BTU management, to natural gas producers and midstream pipeline companies. Its contract treating operations are primarily located in Texas, Louisiana and Arkansas.
The Company competes with PELICO Pipeline, LLC (Pelico), ETP, KMP, Chesapeake Midstream Partners, L.P., Enterprise Products Partners LP, DCP Midstream Partners, L.P., Copano Energy, L.L.C, Southern Union Gas Services, Targa Resources Partners L.P., ONEOK Partners L.P., Penn Virginia Resource Partners, L.P., CenterPoint Energy Transmission, Gulf South Pipeline, L.P., Texas Gas Transmission, LLC, Gulf Crossing Pipeline, Centerpoint Energy Gas Transmission and Natural Gas Pipeline Co. of America, Ext! erran Hol! dings, Inc., Compressor Systems, Inc., USA Compression, Valerus Compression Services LP, J-W Energy Company, TransTex Gas Services, LP, Cardinal Midstream LLC, SouthTex Treaters, Interstate Treating Inc., Thomas Russell Co. and Spartan Energy Group.
Advisors' Opinion:- [By Robert Rapier]
But it is important to note that ETE also has interests in Sunoco Logistics Partners (NYSE: SXL) and Regency Energy Partners (NYSE: RGP).
Finally, consider NuStar Energy (NYSE: NS) and its general partner NuStar GP Holdings (NYSE: NSH). Like ETE, NSH went public in 2006 and has also significantly outperformed its limited partner since:
The vast majority of partnerships don’t have a publicly-traded GP. But in each of these three cases in which the GP is publicly traded, the GP tends to outperform the LP units on long-term gains, an advantage somewhat offset by the typically higher LP yield.
- [By Garrett Cook]
Utilities sector was the top gainer in the US market on Thursday. Top gainers in the sector included Cleco (NYSE: CNL), Korea Electric Power (NYSE: KEP), and Regency Energy Partners LP (NYSE: RGP).
- [By Robert Rapier]
Some of the criteria for inclusion into this index are that units must have a market capitalization of at least $500 million and trade on the New York Stock Exchange or the Nasdaq. Component partnerships will have also maintained or grown distributions quarter-over-quarter for at least one of the trailing two quarters, and they must have a policy intended to consistently maintain or increase distributions over time (i.e., no variable-distribution MLPs).
Because this is an equal-weighted, periodically rebalanced index, top holdings show the MLPs that have outperformed the overall index, while the biggest losers will be found at the bottom of the portfolio. Presently, Crosstex Energy (Nasdaq: XTEX) comprises 6.4 percent of the overall index, reflecting its nearly 30 percent gain in October. Regency Energy Partners (NYSE: RGP) has been the laggard of the group (albeit just barely), falling to 4.84 percent of the overall index makeup.
The total market cap of the ANGI is $190 billion, and the one-, three- and five-year total returns are 29 percent, 52 percent and 249 percent. The index yield is 6 percent.
No comments:
Post a Comment